The lupus Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lupus Hub cannot guarantee the accuracy of translated content. The lupus and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lupus Hub is an independent medical education platform, supported through a grant from AstraZeneca. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out moreCreate an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lupus content recommended for you
Skin involvement can occur as part of systemic lupus erythematosus or as an isolated manifestation of disease; cutaneous lupus erythematosus (CLE). CLE can be categorized as LE-specific or LE-nonspecific manifestations. LE-specific disease can be further subdivided into acute CLE, subacute CLE, chronic CLE (also known as discoid CLE), and intermittent CLE (also known as lupus erythematosus tumidus or tumid lupus). These LE-specific manifestations of CLE are characterized by interface dermatitis, which may also be seen in other skin diseases; therefore, a biopsy is required to confirm a CLE diagnosis prior to treatment. LE-nonspecific CLE manifestations, such as vasculitis and livedo racemosa, are considered signs of thrombotic vasculopathy.
Filter by content: